Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections.
Schutze GE, Gilliam CH, Jin S, Cavenaugh CK, Hall RW, Bradsher RW, Jacobs RF. Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections. Pediatr Infect Dis J. 2004 Feb; 23(2):110-4.